Comparing bevacizumab and ranibizumab for treatment of neovascular age-related macular degeneration: a meta-analysis of noninferiority randomized controlled trials Article

Wang, Xiaotang, Qin, Dan, Liu, Yong et al. (2018). Comparing bevacizumab and ranibizumab for treatment of neovascular age-related macular degeneration: a meta-analysis of noninferiority randomized controlled trials . 11(11), 11663-11672.

cited authors

  • Wang, Xiaotang; Qin, Dan; Liu, Yong; Lei, Runjia; Ren, Meixia; Wang, Runsheng; Wang, Ying

sustainable development goals

authors

publication date

  • January 1, 2018

keywords

  • AVASTIN
  • CLINICAL MEASURES
  • Life Sciences & Biomedicine
  • Medicine, Research & Experimental
  • Neovascular age-related macular degeneration
  • Research & Experimental Medicine
  • Science & Technology
  • THERAPY
  • VISUAL FUNCTION
  • bevacizumab
  • meta-analysis
  • ranibizumab

publisher

  • E-CENTURY PUBLISHING CORP

start page

  • 11663

end page

  • 11672

volume

  • 11

issue

  • 11